Literature DB >> 11914413

Normobaric hyperoxia reduces MRI diffusion abnormalities and infarct size in experimental stroke.

Aneesh B Singhal1, Rick M Dijkhuizen, Bruce R Rosen, Eng H Lo.   

Abstract

BACKGROUND: Hyperbaric oxygen therapy is considered an important stroke treatment strategy.
BACKGROUND: To determine whether normobaric oxygen is neuroprotective, and, if so, what the therapeutic time window is.
METHODS: Experiment 1-Serial diffusion- and perfusion-weighted MRI (DWI and PWI) was performed after middle cerebral artery filament occlusion (MCAO) in rats randomized to FiO(2) 30% (normoxia) or FiO(2) 100% (hyperoxia). Experiment 2-48-hour lesion volumes were analyzed in rats subjected to 2-hour MCAO and randomized to normoxia or hyperoxia starting 15, 30, or 45 minutes after MCAO and ending 15 minutes after reperfusion.
RESULTS: Experiment 1-Lesion apparent diffusion coefficient (ADC) values were persistently low in normoxic animals. In hyperoxia-treated rats, ADC values in cortical border zones showed progressive recovery from 66 +/- 3% of contralateral before hyperoxia, to 104 +/- 20% at approximately 2 hours. Striatal ADC values showed early but ill-sustained improvement. ADC lesion volumes increased progressively in the normoxia group. In the hyperoxia group, ADC lesion volumes tended to decrease after starting hyperoxia; however, lesions later increased in size, and 2-hour lesion volumes were not significantly different from baseline. PWI showed stable right MCA hypoperfusion in all animals. Experiment 2-Hyperoxia within 30 minutes significantly reduced total and cortical lesion volumes at 48 hours after stroke. Striatal lesion volumes were significantly reduced in the hyperoxia-15 group.
CONCLUSION: In rats subjected to transient stroke, 100% oxygen administered within 30 minutes salvages ischemic brain tissue, especially in the cerebral cortex. Reducing the time to treatment enhances the degree of neuroprotection.

Entities:  

Mesh:

Year:  2002        PMID: 11914413     DOI: 10.1212/wnl.58.6.945

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  61 in total

1.  Endothelial dysfunction abrogates the efficacy of normobaric hyperoxia in stroke.

Authors:  Hwa Kyoung Shin; Fumiaki Oka; Ji Hyun Kim; Dmitriy Atochin; Paul L Huang; Cenk Ayata
Journal:  J Neurosci       Date:  2014-11-12       Impact factor: 6.167

2.  Reversal of restricted diffusion in cerebral venous thrombosis: case report.

Authors:  D Sarma; R I Farb; D J Mikulis; K G terBrugge
Journal:  Neuroradiology       Date:  2004-01-16       Impact factor: 2.804

3.  Delayed and multiple hyperbaric oxygen treatments expand therapeutic window in rat focal cerebral ischemic model.

Authors:  Dali Yin; John H Zhang
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

Review 4.  Advances in emerging nondrug therapies for acute stroke 2007.

Authors:  Aneesh B Singhal; Eng H Lo
Journal:  Stroke       Date:  2008-01-10       Impact factor: 7.914

Review 5.  Experimental models, neurovascular mechanisms and translational issues in stroke research.

Authors:  E H Lo
Journal:  Br J Pharmacol       Date:  2007-12-24       Impact factor: 8.739

Review 6.  Clinical trials for cytoprotection in stroke.

Authors:  Lise A Labiche; James C Grotta
Journal:  NeuroRx       Date:  2004-01

Review 7.  The physiology behind direct brain oxygen monitors and practical aspects of their use.

Authors:  Eileen Maloney-Wilensky; Peter Le Roux
Journal:  Childs Nerv Syst       Date:  2010-04       Impact factor: 1.475

8.  A Dual Role for Hyperbaric Oxygen in Stroke Neuroprotection: Preconditioning of the Brain and Stem Cells.

Authors:  Grant M Liska; Trenton Lippert; Eleonora Russo; Norton Nieves; Cesar V Borlongan
Journal:  Cond Med       Date:  2018-06

9.  Protection against focal ischemic injury to the brain by trans-sodium crocetinate. Laboratory investigation.

Authors:  Hiroaki Manabe; David O Okonkwo; John L Gainer; Ryon H Clarke; Kevin S Lee
Journal:  J Neurosurg       Date:  2010-10       Impact factor: 5.115

10.  Normobaric hyperoxia attenuates early blood-brain barrier disruption by inhibiting MMP-9-mediated occludin degradation in focal cerebral ischemia.

Authors:  Wenlan Liu; Jill Hendren; Xu-Jun Qin; Jiangang Shen; Ke Jian Liu
Journal:  J Neurochem       Date:  2009-02       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.